Friday, 20 October 2017

Drug clinically interacting with ribosomes | PGI Nov 2017 Preparations MCQ


Drug clinically interacting with ribosomes to interfere with translation in bacteria 

A. Tetracycline 
B. Erythromycin 
C. Puromycin
D. Oligomycin
E. None


. Answer. A. Teracycline ; (B) Erythromycin :
• The process of translation is divided into :
— Initiation 
 — Elongation
— Termination.
, Streptomycin binds to the 30 S sub-units and distorts its structure, interfering with the initiation of protein synthesis.
• Tetracyclines interact with small ribosomal sub-units blocking access of the amino-acyl t-RNA to the m-RNA ribosome complex.
• Puromycin, chloramphenicol inhibits elongation.
• Clindamycin Erythromycin bind irreversibly to a site of 50S submit of the bacterial ribosome and inhibit translation. Though puromycin inhibits translation , it does not interfere with ribosomes